Bausch + Lomb Announces First-Quarter 2024 Results
Bausch + Lomb Corporation (BLCO)
Company Research
Source: Business Wire
Revenue of $1.099 BillionGAAP Net Loss Attributable to Bausch + Lomb Corporation of $167 MillionAdjusted EBITDA (non-GAAP)1 of $180 MillionRevenue Grew 18% as Reported and 20% on a Constant Currency1 Basis Compared to the First Quarter of 2023, Driven by Growth Across All Business SegmentsForeign Exchange Negatively Impacted Revenue by Approximately $20 MillionRaising Full-Year 2024 Constant Currency Revenue Growth1 Guidance VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quarter 2024 financial results.“Outperformance from each of our business units and solid results across geographies led to an impressive quarter and once again demonstrated our quality of growth,” said Brent Saunders, chairman and CEO, Bausch + Lomb. “Our key franchises continue to deliver, and a focus on returning to our roots by prioritizing innovation is producing t
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Bausch Health Announces 2024 Annual Meeting of Shareholder Results [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Co. (NYSE: BLCO) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $18.00 price target on the stock, up previously from $16.00.MarketBeat
- Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall [Yahoo! Finance]Yahoo! Finance
- Why Bausch Health Companies Stock Dived by More Than 7% Today [Yahoo! Finance]Yahoo! Finance
BLCO
Earnings
- 5/1/24 - Miss
BLCO
Sec Filings
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 4/29/24 - Form ARS
- BLCO's page on the SEC website